One time high-flier Avigilon (Avigilon Stock Quote, Chart, News: TSX:AVO) has been beaten down to levels that make it extremely attractive, says one fund manager.
Patrick Horan, principal, Agilith Capital was on BNN’s Market Call Tonight yesterday and revealed his top picks. Vancouver-based next-gen security provider Avigilon, a former market darling whose stock has fallen on hard times, was one of them.
Horan says despite the fact that the company’s stock price has stopped growing, its business hasn’t.
“This company has more organic growth than I see in the Canadian space in general,” he said. “I don’t see any other stock growing like these guys.”
The fund manager says Avigilon, which has fallen nearly in half from its January high of $34.00, may have actually transitioned its investment profile from growth to value.
“You’re getting it really inexpensive here,” said Horan. “I think its trading at 1.7 times sales, which is a discount to its peer group which is trading at 2.7 times sales, and its growing at double its peer group”.
On August 7th, Avigilon reported its Q2, 2014 results. The company earned $2.8-million on revenue of $65.2-million, up 66% over the previous year’s second quarter topline of $39.2-million.
Horan says Avigilon has been subject to the fickle tastes of the market.
“This is a case where it had “momentumitis”, now no one wants to hold it,” he said. It’s a very good time to own it, as far as we’re concerned”.
At press time, shares of AVO were up 4.1% to $18.63.
ATB Capital Markets analyst Tim Monachello raised his rating on Questor Technology (Questor Technology Stock Quote, Chart, News, Analysts, Financials… [Read More]
Ventum Capital Markets analyst Amr Ezzat maintained a “Buy” rating and C$47.00 target price for Tecsys (Tecsys Stock Quote, Chart,… [Read More]
Roth Capital Markets analyst Scott Searle maintained a “Buy” rating and US$17.50 target price for Gogo (Gogo Stock Quote, Chart,… [Read More]
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$12.00 target price on Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock… [Read More]
Paradigm Capital analyst Marvin Wolff maintained a “Buy” rating and $0.55 target price for CHAR Technologies (CHAR Technologies Stock Quote,… [Read More]
Beacon Securities analyst Donangelo Volpe maintained a “Buy” rating and $2.00 target price for Imaflex (Imaflex Stock Quote, Chart, News,… [Read More]